Royce & Associates LP Raises Position in Cognex Corporation $CGNX

Royce & Associates LP lifted its stake in shares of Cognex Corporation (NASDAQ:CGNX) by 1.0% in the 4th quarter, HoldingsChannel reports. The firm owned 1,057,659 shares of the scientific and technical instruments company’s stock after buying an additional 10,290 shares during the quarter. Royce & Associates LP’s holdings in Cognex were worth $38,055,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. REAP Financial Group LLC purchased a new stake in shares of Cognex during the 3rd quarter worth approximately $27,000. Geneos Wealth Management Inc. boosted its holdings in Cognex by 402.2% in the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after buying an additional 736 shares during the period. CIBC Private Wealth Group LLC boosted its holdings in Cognex by 74.8% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after buying an additional 327 shares during the period. Miller Global Investments LLC bought a new position in Cognex in the 4th quarter worth approximately $39,000. Finally, Larson Financial Group LLC boosted its holdings in Cognex by 202.7% in the 4th quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company’s stock worth $40,000 after buying an additional 740 shares during the period. Hedge funds and other institutional investors own 88.12% of the company’s stock.

Cognex Price Performance

Shares of NASDAQ:CGNX opened at $66.09 on Tuesday. The firm has a fifty day moving average price of $55.58 and a two-hundred day moving average price of $46.82. Cognex Corporation has a one year low of $29.00 and a one year high of $71.90. The company has a market cap of $11.00 billion, a price-to-earnings ratio of 78.68 and a beta of 1.48.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.25 by $0.09. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The firm had revenue of $268.44 million during the quarter, compared to the consensus estimate of $245.98 million. During the same period last year, the firm earned $0.14 EPS. The business’s quarterly revenue was up 24.3% compared to the same quarter last year. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Equities research analysts expect that Cognex Corporation will post 1.4 EPS for the current fiscal year.

Cognex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st will be issued a $0.085 dividend. This represents a $0.34 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Thursday, May 21st. Cognex’s dividend payout ratio (DPR) is presently 40.48%.

Insider Buying and Selling at Cognex

In other Cognex news, insider Mark Fennell sold 64,873 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $67.05, for a total value of $4,349,734.65. Following the completion of the transaction, the insider directly owned 11,263 shares of the company’s stock, valued at $755,184.15. This trade represents a 85.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, VP Laura Ann Macdonald sold 98,122 shares of the firm’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $66.80, for a total transaction of $6,554,549.60. Following the completion of the transaction, the vice president directly owned 5,258 shares of the company’s stock, valued at approximately $351,234.40. The trade was a 94.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 204,595 shares of company stock valued at $13,631,580. Insiders own 1.70% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Truist Financial set a $61.00 price objective on shares of Cognex and gave the stock a “hold” rating in a report on Friday, May 8th. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Cognex in a report on Thursday, February 12th. TD Cowen reaffirmed a “buy” rating on shares of Cognex in a report on Tuesday, February 17th. KeyCorp reaffirmed an “overweight” rating and issued a $70.00 price objective (up from $50.00) on shares of Cognex in a report on Friday, February 13th. Finally, Robert W. Baird set a $72.00 price objective on shares of Cognex in a report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $69.36.

Cognex Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.